These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 1966810
1. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins. Paubert-Braquet M, Hosford D, Klotz P, Guilbaud J, Braquet P. J Lipid Mediat; 1990; 2 Suppl():S1-4. PubMed ID: 1966810 [Abstract] [Full Text] [Related]
2. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins. Braquet P, Hosford D, Koltz P, Guilbaud J, Paubert-Braquet M. Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107 [Abstract] [Full Text] [Related]
3. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. Maestre C, Zarco P, Gómez-Guerrero C, González E, Herrero-Beaumont G, Braquet M, Egido J. J Lipid Mediat; 1990 Dec; 2 Suppl():S151-9. PubMed ID: 1966813 [Abstract] [Full Text] [Related]
4. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Földes-Filep E, Braquet P, Filep J. Biochem Biophys Res Commun; 1987 Nov 13; 148(3):1412-7. PubMed ID: 2825685 [Abstract] [Full Text] [Related]
5. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. Riera M, Torras J, Herrero I, Valles J, Paubert-Braquet M, Cruzado JM, Alsina J, Grinyo JM. J Pharmacol Exp Ther; 1997 Feb 13; 280(2):786-94. PubMed ID: 9023292 [Abstract] [Full Text] [Related]
6. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A. Biochem Pharmacol; 2002 Apr 01; 63(7):1241-9. PubMed ID: 11960600 [Abstract] [Full Text] [Related]
7. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils]. Liu BJ, Zhang HT, Zheng MR. Zhonghua Yi Xue Za Zhi; 1994 Jun 01; 74(6):370-2, 392. PubMed ID: 7994650 [Abstract] [Full Text] [Related]
9. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. Cluzel J, Doly M, Bazan NG, Bonhomme B, Braquet P. Ophthalmic Res; 1995 Jun 01; 27(3):153-7. PubMed ID: 8538992 [Abstract] [Full Text] [Related]
10. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Vercellotti GM, Yin HQ, Gustafson KS, Nelson RD, Jacob HS. Blood; 1988 Apr 01; 71(4):1100-7. PubMed ID: 2451547 [Abstract] [Full Text] [Related]
11. Platelet-activating factor (PAF) stimulates phosphatidylinositol hydrolysis in human peripheral blood mononuclear leukocytes. Ng DS, Wong K. Res Commun Chem Pathol Pharmacol; 1989 Nov 01; 66(2):219-31. PubMed ID: 2557657 [Abstract] [Full Text] [Related]
12. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. Yue TL, Stadel JM, Sarau HM, Friedman E, Gu JL, Powers DA, Gleason MM, Feuerstein G, Wang HY. Mol Pharmacol; 1992 Feb 01; 41(2):281-9. PubMed ID: 1311408 [Abstract] [Full Text] [Related]
13. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. Hwang SB. J Biol Chem; 1988 Mar 05; 263(7):3225-33. PubMed ID: 2830276 [Abstract] [Full Text] [Related]
14. The contractile action of platelet-activating factor on gallbladder smooth muscle. Parkman HP, James AN, Ryan JP. Am J Physiol Gastrointest Liver Physiol; 2000 Jul 05; 279(1):G67-72. PubMed ID: 10898747 [Abstract] [Full Text] [Related]
15. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y. J Immunol; 1989 Aug 15; 143(4):1295-302. PubMed ID: 2545786 [Abstract] [Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation. McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P. J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895 [Abstract] [Full Text] [Related]
17. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Gómez-Chiarri M, Ortíz A, Lerma JL, López-Armada MJ, Mampaso F, González E, Egido J. Lab Invest; 1994 Apr 15; 70(4):449-59. PubMed ID: 8176885 [Abstract] [Full Text] [Related]
18. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils. Stewart AG, Harris T. Immunology; 1993 Jan 15; 78(1):152-8. PubMed ID: 8382188 [Abstract] [Full Text] [Related]
19. Guinea-pig treatment with pertussis toxin suppresses macrophage-dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF. Kadiri C, Leduc D, Lefort J, Imaizumi A, Vargaftig BB. Br J Pharmacol; 1992 Dec 15; 107(4):1029-36. PubMed ID: 1334747 [Abstract] [Full Text] [Related]
20. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. Stewart AG, Harris T, De Nichilo M, Lopez AF. Immunology; 1991 Feb 15; 72(2):206-12. PubMed ID: 1849872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]